Watchlist Price Alert

AN2 Therapeutics Inc. (ANTX)

NASDAQ: ANTX · Real-Time Price · USD

1.22

-0.02 (-1.61%)

At close: May 02, 2025, 3:59 PM

1.22

0.41%

After-hours: May 02, 2025, 04:05 PM EDT

AN2 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-51.32M	-64.73M	-40.96M	-21.54M	-13.6M	-5.63M
Depreciation & Amortization	n/a	n/a	-692K	n/a	n/a	n/a
Stock-Based Compensation	8.34M	8.41M	4.39M	974K	40K	n/a
Other Working Capital	-3.64M	5.28M	1.22M	-385K	1.14M	6K
Other Non-Cash Items	-3.28M	-2.8M	77K	53K	6.97M	3.17M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3M	5.83M	3.72M	32K	1.22M	-10K
Operating Cash Flow	-49.26M	-53.29M	-33.46M	-20.48M	-5.36M	-2.49M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-46.75M	-132.18M	-93.84M	-77.27M	n/a	n/a
Sales Maturities Of Investments	101.34M	88.9M	72.06M	27.25M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-21.77K	-50.02K	n/a	n/a
Investing Cash Flow	54.59M	-43.28M	-21.77M	-50.02M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-11K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	372K	465K	-11K	-1.2M	64K	48.5M
Financial Cash Flow	372K	84.99M	70.36M	78.53M	3.84M	8.08M
Net Cash Flow	5.7M	-11.57M	15.12M	8.03M	-1.53M	5.6M
Free Cash Flow	-49.26M	-53.29M	-33.46M	-20.48M	-5.36M	-2.49M